Featured News

COMPANY NEWS

Virginia Workforce Award to AMPEL BioSolutions

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The annual award recognizes Virginia employers who provide high-quality internships to students.

read more
Charlottesville-area company receives praise for internship program

Charlottesville-area company receives praise for internship program

AMPEL BioSolutions, LLC. is being recognized by Virginia officials for its internship program. It is the only tech company in Charlottesville recognized this cycle. AMPEL says its priority is contributing to knowledge of the future. Interns are able to examine RNA, work on projects, and provide design support for doctors

read more
Innovator-of-Year to AMPEL

Innovator-of-Year to AMPEL

CBIC of Virginia honored the  team with “Innovator-of-the-Year” last night June 1st for the AMPEL Genomic Platform of RNA analytics and Machine Learning for dynamic disease management through flare prediction & personalized decision support for drug options. Charlottesville Business Innovation Council (CBIC) presented AMPEL’s “Innovator-of-the-Year” award at the University of Virginia Research Park.

read more
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.

read more
First Lady of Virginia visits AMPEL

First Lady of Virginia visits AMPEL

Suzanne Youngkin shared the goals of the W+g initiative focused on wellbeing and workforce in Virginia during her March 30th visit to AMPEL BioSolutions, a women-owned business founded, headquartered and growing in Charlottesville.  The focus of AMPEL's business is...

read more
Trial of LuPRO mobile app predicts Lupus flares

Trial of LuPRO mobile app predicts Lupus flares

CLICK TO VIEW ORIGINAL ARTICLE > BY KATIE O'CONNOR, Richmond Times-Dispatch In 50 years, only one treatment was approved by the U.S. Food and Drug Administration to treat lupus, an autoimmune disease in which a person’s immune system attacks their healthy organs...

read more

Pin It on Pinterest